Can an improvement in sleep positively impact on health?

Sleep Medicine Reviews

Volumn 14, Issue 6, 2010, Pages 405-410

  Buysse, Daniel J ^a   Grunstein, Ron ^b   Horne, Jim ^c   Lavie, Peretz ^d  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c LOUGHBOROUGH UNIVERSITY   (United Kingdom)

^d TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Daytime sleepiness; Health; Performance; Sleep deficit; Sleep need; Sleeping time

Indexed keywords

ARTERY CALCIFICATION; CARDIOVASCULAR DISEASE; DAYTIME SOMNOLENCE; DEPRESSION; HUMAN; INFLAMMATION; INSOMNIA; NOTE; RISK FACTOR; SLEEP; SLEEP APNEA SYNDROME; SLEEP DEPRIVATION; SLEEP PATTERN; SLEEP TIME; STROKE;

ANXIETY DISORDERS; COMORBIDITY; DEPRESSION; HEALTH BEHAVIOR; HEALTH PROMOTION; HUMANS; PRACTICE GUIDELINES AS TOPIC; QUALITY ASSURANCE, HEALTH CARE; QUALITY OF LIFE; SLEEP; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 77957873169     PISSN: 10870792     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.smrv.2010.02.001     Document Type: Note

References (77)

1. Dinges D.F., Pack F., Williams K., Gillen K.A., Powell J.W., Ott G.E., et al. Cumulative sleepiness, mood disturbance, and psychomotor vigilance performance decrements during a week of sleep restricted to 4-5 hours per night. Sleep 1997, 20:267-277.
2. Van Dongen H.P., Maislin G., Mullington J.M., Dinges D.F. The cumulative cost of additional wakefulness: dose-response effects on neurobehavioral functions and sleep physiology from chronic sleep restriction and total sleep deprivation. Sleep 2003, 26:117-126.
3. Ohayon M.M., Caulet M., Philip P., Guilleminault C., Priest R.G. How sleep and mental disorders are related to complaints of daytime sleepiness. Arch Intern Med 1997, 157:2645-2652.
4. Gander P., Purnell H., Garden A., Woodward A. Work patterns and fatigue-related risk among junior doctors. Occup Environ Med 2007, 64:733-738.
5. Mollicone D., Van Dongen H., Dinges D.F. PVT performance as a function of total sleep time in a dose response sleep restriction experiment with and without naps. Sleep 2008, 31:A133.
6. Hamblin J.E. Insomnia: an ignored health problem. Prim Care 2007, 34:659-674.
7. Knutson K.L., Van Cauter E. Associations between sleep loss and increased risk of obesity and diabetes. Ann N Y Acad Sci 2008, 1129:287-304.
8. Meerlo P., Sgoifo A., Suchecki D. Restricted and disrupted sleep: effects on autonomic function, neuroendocrine stress systems and stress responsivity. Sleep Med Rev 2008, 12:197-210.
9. Landrigan C.P., Czeisler C.A., Barger L.K., Ayas N.T., Rothschild J.M., Lockley S.W. Effective implementation of work-hour limits and systemic improvements. Jt Comm J Qual Patient Saf 2007, 33:19-29.
10. Lockley S.W., Cronin J.W., Evans E.E., Cade B.E., Lee C.J., Landrigan C.P., et al. Effect of reducing interns' weekly work hours on sleep and attentional failures. N Engl J Med 2004, 351:1829-1837.
11. Spiegel K., Leproult R., Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet 1999, 354:1435-1439.
12. Cappuccio F.P., Taggart F.M., Kandala N.B., Currie A., Peile E., Stranges S., et al. Meta-analysis of short sleep duration and obesity in children and adults. Sleep 2008, 31:619-626.
13. Stranges S., Dorn J.M., Shipley M.J., Kandala N.B., Trevisan M., Miller M.A., et al. Correlates of short and long sleep duration: a cross-cultural comparison between the United Kingdom and the United States: the Whitehall II Study and the Western New York Health Study. Am J Epidemiol 2008, 168:1353-1364.
14. Marshall N.S., Glozier N., Grunstein R.R. Is sleep duration related to obesity? A critical review of the epidemiological evidence. Sleep Med Rev 2008, 12:289-298.
15. Sanders M.H., Montserrat J.M., Farre R., Givelber R.J. Positive pressure therapy: a perspective on evidence-based outcomes and methods of application. Proc Am Thorac Soc 2008, 5:161-172.
16. Marin J.M., Carrizo S.J., Vicente E., Agusti A.G. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005, 365:1046-1053.
17. Ballester E., Badia J.R., Hernandez L., Carrasco E., de Pablo J., Fornas C., et al. Evidence of the effectiveness of continuous positive airway pressure in the treatment of sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 1999, 159:495-501.
18. Barnes M., Houston D., Worsnop C.J., Neill A.M., Mykytyn I.J., Kay A., et al. A randomized controlled trial of continuous positive airway pressure in mild obstructive sleep apnea. Am J Respir Crit Care Med 2002, 165:773-780.
19. Douglas N.J. Systematic review of the efficacy of nasal CPAP. Thorax 1998, 53:414-415.
20. Engleman H.M., Kingshott R.N., Wraith P.K., Mackay T.W., Deary I.J., Douglas N.J. Randomized placebo-controlled crossover trial of continuous positive airway pressure for mild sleep Apnea/Hypopnea syndrome. Am J Respir Crit Care Med 1999, 159:461-467.
21. Engleman H.M., Martin S.E., Deary I.J., Douglas N.J. Effect of CPAP therapy on daytime function in patients with mild sleep apnoea/hypopnoea syndrome. Thorax 1997, 52:114-119.
22. Jenkinson C., Davies R.J., Mullins R., Stradling J.R. Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial. Lancet 1999, 353:2100-2105.
23. Jenkinson C., Davies R.J., Mullins R., Stradling J.R. Long-term benefits in self-reported health status of nasal continuous positive airway pressure therapy for obstructive sleep apnoea. QJM 2001, 94:95-99.
24. Meslier N., Lebrun T., Grillier-Lanoir V., Rolland N., Henderick C., Sailly J.C., et al. A French survey of 3,225 patients treated with CPAP for obstructive sleep apnoea: benefits, tolerance, compliance and quality of life. Eur Respir J 1998, 12:185-192.
25. Monasterio C., Vidal S., Duran J., Ferrer M., Carmona C., Barbe F., et al. Effectiveness of continuous positive airway pressure in mild sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med 2001, 164:939-943.
26. Moyer C.A., Sonnad S.S., Garetz S.L., Helman J.I., Chervin R.D. Quality of life in obstructive sleep apnea: a systematic review of the literature. Sleep Med 2001, 2:477-491.
27. Sanner B.M., Klewer J., Trumm A., Randerath W., Kreuzer I., Zidek W. Long-term treatment with continuous positive airway pressure improves quality of life in obstructive sleep apnoea syndrome. Eur Respir J 2000, 16:118-122.
28. Hack M., Davies R.J., Mullins R., Choi S.J., Ramdassingh-Dow S., Jenkinson C., et al. Randomised prospective parallel trial of therapeutic versus subtherapeutic nasal continuous positive airway pressure on simulated steering performance in patients with obstructive sleep apnoea. Thorax 2000, 55:224-231.
29. Volna J., Sonka K. Medical factors of falling asleep behind the wheel. Prague Med Rep 2006, 107:290-296.
30. Winkelman J.W., Shahar E., Sharief I., Gottlieb D.J. Association of restless legs syndrome and cardiovascular disease in the Sleep Heart Health Study. Neurology 2008, 70:35-42.
31. Botteman M. Health economics of insomnia therapy: implications for policy. Sleep Med 2009, 10(Suppl. 1):S22-S25.
32. Krystal A.D., Erman M., Zammit G.K., Soubrane C., Roth T. Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study. Sleep 2008, 31:79-90.
33. Fava M., McCall W.V., Krystal A., Wessel T., Rubens R., Caron J., et al. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder. Biol Psychiatry 2006, 59:1052-1060.
34. Manber R., Edinger J.D., Gress J.L., San Pedro-Salcedo M.G., Kuo T.F., Kalista T. Cognitive behavioral therapy for insomnia enhances depression outcome in patients with comorbid major depressive disorder and insomnia. Sleep 2008, 31:489-495.
35. Pollack M., Kinrys G., Krystal A., McCall W.V., Roth T., Schaefer K., et al. Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder. Arch Gen Psychiatry 2008, 65:551-562.
36. Tucker A.M., Dinges D.F., Van Dongen H.P. Trait interindividual differences in the sleep physiology of healthy young adults. J Sleep Res 2007, 16:170-180.
37. Phillips B., Mannino D.M. Does insomnia kill?. Sleep 2005, 28:965-971.
38. Dew M.A., Hoch C.C., Buysse D.J., Monk T.H., Begley A.E., Houck P.R., et al. Healthy older adults' sleep predicts all-cause mortality at 4 to 19 years of follow-up. Psychosom Med 2003, 65:63-73.
39. Lavie P., Lavie L. Unexpected survival advantage in elderly people with moderate sleep apnoea. J Sleep Res 2009, 18:397-403.
40. Amagai Y., Ishikawa S., Gotoh T., Doi Y., Kayaba K., Nakamura Y., et al. Sleep duration and mortality in Japan: the Jichi Medical School Cohort Study. J Epidemiol 2004, 14:124-128.
41. Burazeri G., Gofin J., Kark J.D. Over 8 hours of sleep-marker of increased mortality in Mediterranean population: follow-up population study. Croat Med J 2003, 44:193-198.
42. Ferrie J.E., Shipley M.J., Cappuccio F.P., Brunner E., Miller M.A., Kumari M., et al. A prospective study of change in sleep duration: associations with mortality in the Whitehall II cohort. Sleep 2007, 30:1659-1666.
43. Gangwisch J.E., Heymsfield S.B., Boden-Albala B., Buijs R.M., Kreier F., Opler M.G., et al. Sleep duration associated with mortality in elderly, but not middle-aged, adults in a large US sample. Sleep 2008, 31:1087-1096.
44. Goto A., Yasumura S., Nishise Y., Sakihara S. Association of health behavior and social role with total mortality among Japanese elders in Okinawa, Japan. Aging Clin Exp Res 2003, 15:443-450.
45. Heslop P., Smith G.D., Metcalfe C., Macleod J., Hart C. Sleep duration and mortality: the effect of short or long sleep duration on cardiovascular and all-cause mortality in working men and women. Sleep Med 2002, 3:305-314.
46. Ikehara S., Iso H., Date C., Kikuchi S., Watanabe Y., Wada Y., et al. Association of sleep duration with mortality from cardiovascular disease and other causes for Japanese men and women: the JACC study. Sleep 2009, 32:295-301.
47. Kojima M., Wakai K., Kawamura T., Tamakoshi A., Aoki R., Lin Y., et al. Sleep patterns and total mortality: a 12-year follow-up study in Japan. J Epidemiol 2000, 10:87-93.
48. Kripke D.F., Garfinkel L., Wingard D.L., Klauber M.R., Marler M.R. Mortality associated with sleep duration and insomnia. Arch Gen Psychiatry 2002, 59:131-136.
49. Lan T.Y., Lan T.H., Wen C.P., Lin Y.H., Chuang Y.L. Nighttime sleep, Chinese afternoon nap, and mortality in the elderly. Sleep 2007, 30:1105-1110.
50. Patel S.R., Ayas N.T., Malhotra M.R., White D.P., Schernhammer E.S., Speizer F.E., et al. A prospective study of sleep duration and mortality risk in women. Sleep 2004, 27:440-444.
51. Shankar A., Koh W.P., Yuan J.M., Lee H.P., Yu M.C. Sleep duration and coronary heart disease mortality among Chinese adults in Singapore: a population-based cohort study. Am J Epidemiol 2008, 168:1367-1373.
52. Tamakoshi A., Ohno Y. Self-reported sleep duration as a predictor of all-cause mortality: results from the JACC study. Japan. Sleep 2004, 27:51-54.
53. Qureshi A.I., Giles W.H., Croft J.B., Bliwise D.L. Habitual sleep patterns and risk for stroke and coronary heart disease: a 10-year follow-up from NHANES I. Neurology 1997, 48:904-911.
54. Horne J. Is there a sleep debt?. Sleep 2004, 27:1047-1049.
55. Anderson C., Horne J.A. Do we really want more sleep? A population-based study evaluating the strength of desire for more sleep. Sleep Med 2008, 9:184-187.
56. Horne J. Sleepiness as a need for sleep: when is enough, enough?. Neurosci Biobehav Rev 2010, 34:108-118.
57. Totterdell P., Reynolds S., Parkinson B., Briner R.B. Associations of sleep with everyday mood, minor symptoms and social interaction experience. Sleep 1994, 17:466-475.
58. Horne J. Short sleep is a questionable risk factor for obesity and related disorders: statistical versus clinical significance. Biol Psychol 2008, 77:266-276.
59. Bjorvatn B., Sagen I.M., Oyane N., Waage S., Fetveit A., Pallesen S., et al. The association between sleep duration, body mass index and metabolic measures in the Hordaland Health Study. J Sleep Res 2007, 16:66-76.
60. Chaput J.P., Despres J.P., Bouchard C., Tremblay A. Short sleep duration is associated with reduced leptin levels and increased adiposity: results from the Quebec family study. Obesity (Silver Spring) 2007, 15:253-261.
61. Gangwisch J.E., Malaspina D., Boden-Albala B., Heymsfield S.B. Inadequate sleep as a risk factor for obesity: analyses of the NHANES I. Sleep 2005, 28:1289-1296.
62. Hasler G., Buysse D.J., Klaghofer R., Gamma A., Ajdacic V., Eich D., et al. The association between short sleep duration and obesity in young adults: a 13-year prospective study. Sleep 2004, 27:661-666.
63. Patel S.R., Malhotra A., White D.P., Gottlieb D.J., Hu F.B. Association between reduced sleep and weight gain in women. Am J Epidemiol 2006, 164:947-954.
64. Groeger J.A., Zijlstra F.R., Dijk D.J. Sleep quantity, sleep difficulties and their perceived consequences in a representative sample of some 2000 British adults. J Sleep Res 2004, 13:359-371.
65. Spiegel K., Knutson K., Leproult R., Tasali E., Van Cauter E. Sleep loss: a novel risk factor for insulin resistance and Type 2 diabetes. J Appl Physiol 2005, 99:2008-2019.
66. Ayas N.T., White D.P., Al-Delaimy W.K., Manson J.E., Stampfer M.J., Speizer F.E., et al. A prospective study of self-reported sleep duration and incident diabetes in women. Diabetes Care 2003, 26:380-384.
67. Lumeng J.C., Somashekar D., Appugliese D., Kaciroti N., Corwyn R.F., Bradley R.H. Shorter sleep duration is associated with increased risk for being overweight at ages 9 to 12 years. Pediatrics 2007, 120:1020-1029.
68. von Kries R., Toschke A.M., Wurmser H., Sauerwald T., Koletzko B. Reduced risk for overweight and obesity in 5- and 6-y-old children by duration of sleep-a cross-sectional study. Int J Obes Relat Metab Disord 2002, 26:710-716.
69. Gottlieb D.J., Redline S., Nieto F.J., Baldwin C.M., Newman A.B., Resnick H.E., et al. Association of usual sleep duration with hypertension: the Sleep Heart Health Study. Sleep 2006, 29:1009-1014.
70. Zepelin H., Siegel J.M., Tobler I. Mammalian sleep. Principles and practice of sleep medicine 2005, 91-100. Elsevier/Saunders, Philadelphia. 4th ed. M.H. Kryger, T. Roth, W.C. Dement (Eds.).
71. Ekirch A.R. At day's close: night in time's past 2005, W.W. Norton & Company, Inc., New York.
72. Fava M., Asnis G.M., Shrivastava R., Lydiard B., Bastani B., Sheehan D., et al. Zolpidem extended-release improves sleep and next-day symptoms in comorbid insomnia and generalized anxiety disorder. J Clin Psychopharmacol 2009, 29:222-230.
73. Giles T.L., Lasserson T.J., Smith B.H., White J., Wright J., Cates C.J. Continuous positive airways pressure for obstructive sleep apnoea in adults. Cochrane Database Syst Rev 2006, 3. CD001106.
74. Young T., Finn L., Peppard P.E., Szklo-Coxe M., Austin D., Nieto F.J., et al. Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort. Sleep 2008, 31:1071-1078.
75. Redenius R., Murphy C., O'Neill E., Al-Hamwi M., Zallek S.N. Does CPAP lead to change in BMI?. J Clin Sleep Med 2008, 4:205-209.
76. Kraemer H.C., Kazdin A.E., Offord D.R., Kessler R.C., Jensen P.S., Kupfer D.J. Coming to terms with the terms of risk. Arch Gen Psychiatry 1997, 54:337-343.
77. Horne J. Primary insomnia: a disorder of sleep, or primarily one of wakefulness?. Sleep Med Rev 2010, 14:3-7.